Get the Stockscreener App
3.03
7.45%
0.2101
Xenetic Biosciences Inc stock is traded at $3.03, with a volume of 20,458.
It is up +7.45% in the last 24 hours and down -15.13% over the past month.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
See More
Previous Close:
$2.8199
Open:
$2.8
24h Volume:
20,458
Relative Volume:
0.28
Market Cap:
$4.67M
Revenue:
$2.54M
Net Income/Loss:
$-4.13M
P/E Ratio:
-1.1018
EPS:
-2.75
Net Cash Flow:
$-4.11M
1W Performance:
+5.94%
1M Performance:
-15.13%
6M Performance:
-24.79%
1Y Performance:
-29.98%
1-Day Range:
$2.7193
$3.15
1-Week Range:
$2.7193
$3.15
52-Week Range:
$2.20
$5.2683
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Name
Xenetic Biosciences Inc
Sector
Industry
Phone
781-778-7720
Address
945 CONCORD ST., FRAMINGHAM, MA
Compare XBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
3.03 | 4.53M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-20 | Initiated | Maxim Group | Buy |
Xenetic Biosciences Inc Stock (XBIO) Latest News
Key metrics from Xenetic Biosciences Inc.’s quarterly dataMarket Performance Report & High Accuracy Investment Signals - Newser
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Short Interest Update - Defense World
Published on: 2025-08-20 04:52:07 - Newser
Xenetic Biosciences Inc. stock volume spike explained2025 Market Trends & High Accuracy Swing Entry Alerts - Newser
Price momentum metrics for Xenetic Biosciences Inc. explainedCPI Data & Weekly Return Optimization Plans - Newser
Evaluating Xenetic Biosciences Inc. with trendline analysisQuarterly Market Summary & Daily Price Action Insights - Newser
What the charts say about Xenetic Biosciences Inc. today2025 Price Action Summary & High Conviction Investment Ideas - Newser
Technical analysis overview for Xenetic Biosciences Inc. stockTrade Risk Report & Free High Return Stock Watch Alerts - Newser
What recovery options are there for Xenetic Biosciences Inc.Quarterly Risk Review & Real-Time Volume Trigger Notifications - Newser
Will Xenetic Biosciences Inc. benefit from macro trendsWeekly Investment Recap & Fast Exit and Entry Strategy Plans - Newser
Top chart patterns to watch in Xenetic Biosciences Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
Can momentum traders help lift Xenetic Biosciences Inc.CPI Data & Stock Portfolio Risk Management - Newser
Leading vs lagging indicators on Xenetic Biosciences Inc. performanceJuly 2025 Movers & Weekly High Return Opportunities - Newser
What to do if you’re stuck in Xenetic Biosciences Inc.2025 Price Momentum & AI Based Trade Execution Alerts - Newser
Published on: 2025-08-18 22:20:52 - Newser
Quantitative breakdown of Xenetic Biosciences Inc. recent move2025 Winners & Losers & Fast Entry High Yield Tips - Newser
Buy Signal for Xenetic Biosciences Inc. Stock Key Technical Indicators to Watch2025 Volume Leaders & AI Driven Stock Movement Reports - Newser
Xenetic Biosciences Inc. stock outlook for YEARJuly 2025 Rallies & Safe Swing Trade Setup Alerts - Newser
What machine learning models say about Xenetic Biosciences Inc.July 2025 Price Swings & Accurate Buy Signal Alerts - Newser
Should you hold or exit Xenetic Biosciences Inc. nowWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - Newser
Is Xenetic Biosciences Inc. stock entering bullish territoryOptions Play & High Win Rate Trade Alerts - Newser
Xenetic Biosciences Inc. stock retracement – recovery analysisTrade Ideas & Free Verified High Yield Trade Plans - Newser
Using flow based indicators on Xenetic Biosciences Inc.July 2025 Momentum & Expert Curated Trade Setup Alerts - Newser
Xenetic Biosciences Inc. stock trend forecastWeekly Investment Summary & Expert Approved Trade Ideas - Newser
HC Wainwright Has Optimistic Outlook of XBIO Q3 Earnings - Defense World
Has Xenetic Biosciences Inc. found a price floorPortfolio Update Summary & Safe Capital Investment Plans - Newser
How Xenetic Biosciences Inc. stock performs during market volatilityJuly 2025 Setups & High Conviction Investment Ideas - Newser
Xenetic Biosciences Inc Stock (XBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):